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Abstract
Mosquitoes are responsible for the transmission of many clinically important arboviruses
that cause significant levels of annual mortality and socioeconomic health burden world-
wide. Deciphering the mechanisms by which mosquitoes modulate arbovirus infection is
crucial to understand how viral-host interactions promote vector transmission and human
disease. SUMOylation is a post-translational modification that leads to the covalent attach-
ment of the Small Ubiquitin-like MOdifier (SUMO) protein to host factors, which in turn can
modulate their stability, interaction networks, sub-cellular localisation, and biochemical func-
tion. While the SUMOylation pathway is known to play a key role in the regulation of host
immune defences to virus infection in humans, the importance of this pathway during arbovi-
rus infection in mosquito vectors, such as Aedes aegypti (Ae. aegypti), remains unknown.
Here we characterise the sequence, structure, biochemical properties, and tissue-specific
expression profiles of component proteins of the Ae. aegypti SUMOylation pathway. We
demonstrate significant biochemical differences between Ae. aegypti and Homo sapiens
SUMOylation pathways and identify cell-type specific patterns of SUMO expression in Ae.
aegypti tissues known to support arbovirus replication. Importantly, depletion of core
SUMOylation effector proteins (SUMO, Ubc9 and PIAS) in Ae. aegypti cells led to enhanced
levels of arbovirus replication from three different families; Zika (Flaviviridae), Semliki Forest
(Togaviridae), and Bunyamwera (Bunyaviridae) viruses. Our findings identify an important
role for mosquito SUMOylation in the cellular restriction of arboviruses that may directly
influence vector competence and transmission of clinically important arboviruses.
Author summary
Half the world’s population is at risk of infection from arboviruses transmitted by mosqui-
toes. Deciphering the viral-host interactions that influence the outcome of arbovirus
infection in mosquitoes is beneficial to the development of future vector control strategies
to limit arbovirus transmission and viral emergence within the human population. Similar
to humans, mosquitoes possess different immune pathways to limit the replication of
arboviruses. While the Small Ubiquitin-like MOdifier (SUMO) pathway is known to play
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an important role in the regulation of immune defences to viral infection in humans, the
influence of this pathway during arbovirus infection in mosquito cells is currently
unknown. Here we define the conservation, biochemical activity, and tissue distribution
of the core effector proteins of the Aedes aegypti SUMOylation pathway. We show that the
mosquito SUMOylation pathway plays a broadly antiviral role against a wide range of
clinically important arboviruses, including Zika, Semliki Forest, and Bunyamwera viruses.
Our findings identify SUMOylation as an important component of the antiviral response
to arbovirus infection in mosquito cells.
Introduction
Many clinically important arthropod-borne viruses (arboviruses), such as dengue (DENV),
Zika (ZIKV) (Flaviviruses; Flaviviridae), chikungunya (CHIKV) (Alphavirus; Togaviridae)
and Rift Valley Fever (Phlebovirus; Bunyaviridae) viruses, are transmitted by the mosquito
vector Aedes aegypti (Ae. aegypti, Aa). Aedes-borne pathogens represent a substantial world-
wide public health burden due to an ever expanding geographical vector range and associated
threat of viral emergence and epidemic disease [1–4]. For example, approximately half of the
world’s population is now estimated to be at risk from DENV with around 390 million new
infections worldwide every year [5]. In addition, arboviral diseases transmitted by Aedes have
an important socioeconomic impact, with the 2015–2016 Zika outbreak in Latin America and
the Caribbean estimated to cost 18 billion USD [6]. Without efficient treatments or vaccines
against the majority of arbovirus infections, vector control is the most widely utilized strategy
to limit viral transmission [7]. Insecticides have been commonly used as the first line of
defence, but increased mosquito resistance hampers their efficacy [8,9]. As such, there is a
need to develop new and effective vector control measures [10]. In this context, it is crucial to
improve our understanding of mosquito biology and mosquito-arbovirus interactions to iden-
tify targets that influence arbovirus infection directly in mosquitoes.
The Small Ubiquitin-like MOdifier (SUMO) protein covalently modifies target proteins (in
a process termed SUMOylation) in a reversible manner. This post-translational modification
regulates a wide variety of cellular processes, including the cell cycle, transcription, DNA
repair, protein stability and sub-cellular localization [11]. In Homo sapiens (H. sapiens), the
process of SUMOylation is conducted in a 3-step enzymatic cascade, involving the E1 SUMO
activating enzyme complex SAE1/2, the E2 conjugating enzyme Ubc9 (UBE2I), and E3 SUMO
ligases, including the Protein Inhibitor of Activated STAT (PIAS) family of proteins [11]. H.
sapiens possess 5 SUMO homologues, of which only SUMO1, 2, and 3 are constitutively
expressed and conjugated to target proteins [12]. SUMO modification typically occurs on
lysine (Lys/K) residues within a SUMO Consensus Motif (SCM) C-Lys-X-[Asp/Glu] of a tar-
get protein, whereC represents a hydrophobic amino acid and X represents any amino acid
[13]. SUMO2 and SUMO3 both contain an internal SCM that readily supports poly-SUMO2/
3 chain formation [14,15]. SUMO chains have many important cellular functions, including
roles in meiosis, mitosis, DNA repair, and proteasomal degradation [16]. In contrast, SUMO1
does not possess an internal SCM, and is therefore generally considered to be conjugated as a
monomer onto target proteins or incorporated into poly-SUMO chains as a chain terminator
[14].
SUMOylation plays an important function, both positively and negatively, in the replication
of a wide range of DNA and RNA viruses in mammalian cells, either directly through the
SUMOylation of viral proteins or indirectly by regulation of immune defences [17–19]. To
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date, studies to determine the role of SUMOylation during arbovirus infection have focused
on flaviviruses in mammalian cells [20–23]. While two of these studies demonstrated depletion
of Ubc9 could restrict DENV replication [20,21], a third study showed that SUMOylation of
the DENV non-structural 5 protein (NS5) decreased ubiquitin-mediated degradation of NS5
to promote infection [23]. This proviral role for host SUMOylation in mammalian cells was
supported by recent findings from Zhu et al. [22], which demonstrated the SUMOylation
inhibitor 2-D08 to decrease flavivirus (ZIKV, DENV, Yellow fever virus, West Nile virus, and
Japenese Encephalitis virus) RNA levels during infection. However, it remains to be deter-
mined what role (proviral or antiviral) SUMOylation plays during arbovirus infection in mos-
quito cells.
Genes of the SUMOylation pathway are conserved in various arthropods, including insects
[24,25]. Most of the knowledge on SUMO function in insects has been gained from studies in
the fruit fly Drosophila melanogaster (D. melanogaster). In this species, SUMO modification is
known to be involved in embryogenesis, metamorphosis, gut regeneration, and innate immu-
nity [26]. However, the functional conservation of the different effectors involved in the
SUMOylation pathway, along with its role during infection with alphaviruses, flaviviruses, and
bunyaviruses in arthropods has yet to be determined.
Here we characterise the sequence homology and functional conservation of the SUMOyla-
tion pathway between Ae. aegypti and H. sapiens. Our analysis reveals that AaSUMO is func-
tionally more comparable to HsSUMO1 than HsSUMO3, the closest related orthologue, due to
the lack of an internal SCM. Consistent with SUMOylation in H. sapiens, we show that the sole
Ae. aegypti PIAS (AaPIAS) SUMO E3 ligase stimulates AaSUMO poly-SUMO chain forma-
tion in a SIZ/PIAS (SP) RING-domain dependent manner. We identify differential patterns of
SUMO expression in Ae. aegypti cells and tissues known to support arbovirus replication.
Finally, we present compelling evidence for a broad antiviral effect of Ae. aegypti host SUMOy-
lation against arboviruses. Depletion of AaSUMO, AaUbc9, or AaPIAS resulted in increased
arbovirus replication from three independent families; bunyamwera virus (BUNV), Semliki
Forest virus (SFV) and ZIKV. To our knowledge, this research is the first study to investigate
the biochemical properties and biological significance of the SUMOylation pathway on arbovi-
rus replication in Ae. aegypti cells. Our findings reveal an important antiviral role for AaSU-
MOylation in the regulation of antiviral defences to arbovirus infection in mosquito cells.
Results
Ae. aegypti and H. sapiens SUMOylation pathways are highly conserved
Bioinformatic studies had previously identified two Ae. aegypti SUMO orthologue genes
(AAEL015064; AAEL013787), along with gene orthologues of SAE1 and SAE2 (AAEL000091
and AAEL010641, respectively), Ubc9 (AAEL007477), and PIAS (AAEL015099) [24,25].
Following the recent re-sequencing and updated annotation of the Ae. aegypti genome
(AaegL5.1, available at https://www.vectorbase.org/; [27]), the gene ID of Ubc9 has changed to
AAEL027903. In addition, our analysis identified only one SUMO gene (AAEL015064), with
sequences relating to the second putative gene (AAEL013787) being re-annotated to that of a
calcium ion transporter gene (AAEL019513). Mass spectrometry analysis of Ae. aegypti AF5
cells identified peptides unique to each protein of the Ae. aegypti SUMOylation pathway
(SUMO [AAEL015064], SAE1/2, Ubc9, and PIAS), with the exception of the putative
AAEL013787 SUMO protein (S1 File). Therefore, AAEL015064 is the only SUMO gene prod-
uct abundantly expressed in Ae. aegypti AF5 cells (hereafter referred to as AaSUMO).
Alignment of SUMOylation effector proteins (SUMO, SAE1/2, Ubc9, and PIAS) between
Ae. aegypti and H. sapiens demonstrated a high degree of protein conservation. AaSAE1,
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AaSAE2, and AaUbc9 shared 42%, 50%, and 85% amino acid identity with their respective H.
sapiens orthologues (Fig 1A). Homology between AaSUMO and HsSUMO1-3 proteins ranged
from 47 to 71% identity, with AaSUMO showing the highest degree of similarity to that of
HsSUMO3 (Fig 1A). Phylogenetic alignment of SUMO proteins from different species
Fig 1. The Aedes aegypti SUMOylation pathway is highly conserved. (A) Colour-coded pairwise identity matrix showing the percentage amino acid
(a.a) identity between orthologue proteins of the Aedes aegypti and Homo sapiens SUMOylation pathways. Each coloured cell represents the percentage
identity score between two sequences. Colour key showing the correspondence between percentage identity and the colours displayed shown. (B)
Phylogenetic tree and N-terminal amino acid alignment of SUMO proteins from a selection of model organisms (SUMO Uniprot accession number).
Hs, Homo sapiens (P55854); Mm, Mus musculus (Q9Z172); Gg, Gallus gallus (Q5ZHQ1); Xl, Xenopus laevis (Q6DK72); Is, Ixodes scapularis (B7PKS5);
Cq, Culex quinquefasciatus (B0WVZ6); Aa, Aedes aegypti (Q16EQ3); Aal, Aedes albopictus (A0A182H3N0); Ag, Anopheles gambiae (Q7PNJ2 and
Q7PY16 +); Dm, Drosophila melanogaster (O97102). Branch lengths are proportional to sequence divergence with bootstrap values shown. Conserved
residues are shown in orange; residues with similarity in green. SUMO consensus motifs (SCM;C-Lys(K)-X-Asp(D)/Glu(E), whereC represents a
branched hydrophobic amino acid and X represents any amino acid) are higlighted in grey. (C) Amino acid alignment of full length AaSUMO plotted
against HsSUMO3. (D) Predicted structure of AaSUMO (blue) plotted against the resolved structure of HsSUMO3 (red; PDB ID: 2MP2; [85]). Position
and sequence of SCM in HsSUMO3 highlighted (VKTE; grey). (E) Phylogenetic tree and amino acid alignment of the catalytic SP-RING domain of
orthologue PIAS proteins from Ae. aegypti and H. sapiens. Uniprot accession numbers; AaPIAS (Q1DH55), HsPIAS1 (O75925), HsPIAS2α (O75928-
2), HsPIAS2β (O75928-1), HsPIAS3 (Q9Y6X2), and HsPIAS4 (Q8N2W9). Branch lengths proportional to sequence divergence with bootstrap values
shown. Residues of AaPIAS 340–418, HsPIAS4 311–388, HsPIAS3 312–390, HsPIAS2α 331–409, HsPIAS2β 331–409, and HsPIAS1 320–398 shown.
Zn2+ binding residues highlighted by grey bars; cysteine (C371) marked with #.
https://doi.org/10.1371/journal.ppat.1009134.g001
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indicated that SUMO orthologues from Ae. aegypti and other mosquito species lack an N-ter-
minal SCM, contrary to the chelicerate Ixodes scapularis and vertebrate SUMO orthologues
(Fig 1B and 1C; [25]). Homology modelling confirmed AaSUMO to contain a classical ubiqui-
tin-related modifier tertiary structure with flexible N- and C-terminal regions (Fig 1D;
[25,28]). In H. sapiens, PIAS SUMO E3 ligases are known to increase the rate of SUMO modi-
fication and poly-SUMO chain formation [29,30]. In contrast to the five PIAS proteins
expressed by H. sapiens, only one PIAS protein has been identified in Ae. aegypti [24]. The
amino acid identity of AaPIAS ranged from 32 to 37% between HsPIAS orthologues, increas-
ing up to 70% in the catalytic SP-RING domain (Fig 1A). Sequence alignment confirmed the
presence of Zn2+-coordinating residues within the SP-RING required for SUMO ligase activity
(Fig 1E; grey bars) [31]. These data indicate that the function of the SP-RING domain is likely
to be conserved between H. sapiens and Ae. aegypti. Overall, our analysis revealed a high
degree of protein conservation between Ae. aegypti and H. sapiens SUMOylation pathways.
These data suggest a functional conservation of this pathway between mosquitoes and humans,
with the notable exception of an absent N-terminal SCM within AaSUMO.
AaPIAS stimulates the efficient formation of poly-AaSUMO chains
As AaSUMO lacks an N-terminal SCM, this protein may not readily support poly-SUMO
chain formation, unlike its closest H. sapiens orthologue HsSUMO3 [14]. We tested this
hypothesis by incubating together recombinant proteins (S1 Fig) of either the AaSUMOylation
pathway (AaSUMO, AaUbc9, and AaSAE1/2) or the HsSUMOylation pathway (HsSUMO3,
HsUbc9, and HsSAE1/2) at either 28 or 37˚C, the optimal temperatures for mosquito and
mammalian cells, respectively. We detected a build-up of AaSUMO-dimers along with high
molecular weight (HMW) SUMO conjugates indicative of SAE1/2 auto-SUMOylation (Fig
2A; [32,33]). The formation of HMW AaSUMO conjugates was more comparable to
HsSUMO1 than HsSUMO3 at either 28 or 37˚C (Fig 2B and 2C). These data indicate that
AaSUMO is more biochemically similar to that of HsSUMO1 than HsSUMO3 with respect to
supporting the formation of HWM SUMO protein conjugates, consistent with the lack of an
internal SCM (Fig 1B; [25]). In order to determine the effect of AaPIAS on poly-AaSUMO
chain formation, biochemical assays were repeated in the presence of wild-type (WT) or cata-
lytically inactive (C371A; Fig 1E) AaPIAS. Addition of WT AaPIAS led to a rapid build-up of
HMW SUMO conjugates relative to AaPIAS C371A (Fig 2D and 2E). Collectively, these data
indicate that AaPIAS stimulates the efficient formation of HMW SUMO conjugates in an
SP-RING dependent manner. We next sought to investigate why AaSUMO could not effi-
ciently form chains in the absence of AaPIAS. We hypothesized that this was due to the
absence of an SCM (Fig 1B; [25]). We generated a chimeric SUMO protein, in which the N-
terminus of AaSUMO (amino acids 1–13) was replaced by the one of HsSUMO3 (amino acids
1–14) to incorporate its SCM. This chimeric SUMO protein was found to support the rapid
build-up of HMW SUMO conjugates in the absence of AaPIAS that was dependent upon the
Lys acceptor residue (K11) within the SCM (Fig 2F). These data demonstrate that while
AaSUMO shares the highest degree of amino acid identity to HsSUMO3, its biochemical activ-
ity as a ubiquitin-like protein is more functionally related to that of HsSUMO1 due to the
absence of a functional SCM.
AaSUMO contains eight Lys residues (Fig 1C) which could act as potential acceptor sites
for SUMO modification in the presence of AaPIAS. We next investigated which Lys residues
within AaSUMO were preferentially modified by AaPIAS. Mass spectrometry analysis was
conducted on SUMO-dimers and HMW poly-SUMO chains generated in the presence or
absence of either WT or C371A AaPIAS (S2 Fig). Spectral analysis demonstrated that
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AaSUMO was preferentially conjugated to surface exposed Lys (K) residues K5, K6, K9, K40,
and to a lesser extent, K33 (Figs 3A and S3 and S2 Files). Addition of AaPIAS increased the
proportion of detectible branched SUMO peptides, consistent with enhanced levels of poly-
SUMO chain formation in a SP-RING dependent manner (Fig 2D and 2E) without strong
preference for any specific solvent-exposed Lys residue (Figs 3B and 3C and S3). Collectively,
these data demonstrate that AaPIAS plays an important role in the SCM-independent forma-
tion of HMW AaSUMO conjugates.
AaSUMO is differentially expressed in Ae. aegypti tissues
To determine if AaSUMO was expressed in tissues relevant to arbovirus infection, we deter-
mined the relative expression levels of SUMO transcripts in multiple mosquito tissues from
female mosquitoes; including salivary glands, digestive tract, ovaries, carcass (remaining
abdominal tissue), and perfused haemocytes (mosquito immune cells). RNA was extracted
and transcript expression levels analysed by RT-qPCR. SUMO transcripts were detected in all
Fig 2. AaPIAS is required for efficient poly-AaSUMO chain formation. Purified Ae. aegypti and H. sapiens SUMO, Ubc9, and SAE1/2 recombinant
proteins (50 ng each per reaction, S1 Fig) were incubated in the presence of 5 mM ATP for the indicated time points (minutes, min). (A) Representative
western blot showing the accumulation of high molecular weight (HMW) SUMO conjugates over time at 28˚C. Free SUMO, SUMO-SUMO dimers,
and HMW conjugates highlighted. Molecular mass markers shown. (B/C) Quantitation of the accumulation of HMW SUMO conjugates (as in A;�
SUMO dimers) at 28 or 37˚C (B and C, respectively). N�3 independent reactions per condition; values normalized to T = 0 min (T0); mean and
standard error of mean plotted. (D/E) Ae. aegypti SUMOylation pathway enzymes were incubated in the presence of WT or catalytically inactive
(C371A) AaPIAS (10 ng) for the indicated time points at 28˚C. (D) Representative western blot showing the accumulation of HMW SUMO conjugates
in the presence of WT AaPIAS. (E) Quantitation of the accumulation of HMW SUMO conjugates (as in D and described in B). (F) Ae. aegypti
SUMOylation pathway enzymes (SAE1/2 and Ubc9) were incubated in the presence of chimaeric SUMO (amino acids 1–14 of HsSUMO3 [including
WT or mutant (K11R) SCM] in frame with the C-terminus of AaSUMO) for the indicate time points at 28˚C. Western blots were quantified for the
accumulation of HMW SUMO conjugates (as described in B).
https://doi.org/10.1371/journal.ppat.1009134.g002
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tissues and haemocytes, with significantly higher levels of SUMO expression observed in hae-
mocytes and ovaries relative to the carcass (Figs 4A and S4).
We next examined the expression pattern of AaSUMO protein in Ae. aegypti. Immunofluo-
rescent confocal microscopy analysis was conducted using polyclonal antibodies raised to
HsSUMO2/3, which detect both unconjugated and conjugated AaSUMO protein (Fig 2A and
2D). Microscopy assays were conducted on cultured Ae. aegypti-derived AF5 cells, perfused
haemocytes, salivary glands, digestive tract, and ovaries from Ae. aegypti NBF females (Fig 4).
Controls without primary antibody were also analysed under the same conditions to ensure
signal specificity to AaSUMO (S5 Fig). In AF5 cells, AaSUMO was predominantly detected as
nuclear punctate structures (Fig 4B and 4C). Consistent with our RT-qPCR results, AaSUMO
expression was detected in perfused haemocytes and in every Ae. aegypti tissue analysed. In
haemocytes, AaSUMO expression was restricted to the nucleus in prohaemocytes (Fig 4D),
which have a high nuclear/cytoplasmic ratio [34], and differentiated granulocytes (Fig 4E),
which are bigger cells with filopodia and a low nuclear/cytoplasmic ratio [34]. Very low levels
of AaSUMO expression were detected in the lobes of salivary glands (Fig 4F), with higher lev-
els of AaSUMO detected in surrounding fat body cells (Fig 4G). In the midgut, AaSUMO was
expressed in the nucleus of enterocytes (recognizable by their large nuclei) and in smaller
enteroendocrine and/or stem cells (Fig 4H). In the ovaries, AaSUMO was found to be highly
expressed in the nuclei of the epithelial cells of the oviduct (Fig 4I). Similar staining was found
in the ovarian sheath surrounding the ovarioles (Fig 4J). In the ovarioles, AaSUMO was
expressed within the primary previtellogenic follicle and in the germarium (Fig 4K and 4L). In
the primary follicle, AaSUMO was detected in the cytoplasm of the follicular cells surrounding
the follicle. A strong circular signal of AaSUMO protein was detected close to the nucleus of
the oocyte (Fig 4K and 4L; white arrows) and at perinuclear regions of nurse cells (Fig 4K; yel-
low arrows). In the germarium, AaSUMO was detected in the nucleus and cytoplasm of germ-
line stem cells and follicle stem cells, in the cystoblasts as well as in the germline and follicular
cells of the developing secondary follicle. Overall, our findings shows that AaSUMO is differ-
entially expressed in multiple tissues and cells known to support arbovirus replication, includ-
ing the gut, ovaries, and haemocytes.
Fig 3. Internal lysine acceptor residues for AaSUMO modification. (A) Summary of mass spectrometry data (S2 Fig) associated with branched SUMO
peptides identified on SUMO Lys (K5, K6, K9, K19, K31, K33, K34, and K40) acceptor residues from in vitro reaction mixtures containing AaSAE1/2,
AaUbc9, and AaSUMO. Data aggregated from all samples. MaxQuant Andromeda (peptide assignment score) values shown. (B) Total branched peptide
intensity for all Lys acceptor residues from in vitro reaction mixtures (as in A) incubated in the presence or absence of WT or catalytically inactive (C371A,
CA) AaPIAS (as shown). (C) Slice-specific (dimeric SUMO, SUMOx2; HWM SUMO conjugates, polySUMO) peptide intensity data of Lys-specific
acceptor residues. Data presented as a percentage of the total intensity of all branched peptides found in each gel slice. Representative spectra can be found
in S7–S14 Figs. Data summary presented in S2 File. N = 3.
https://doi.org/10.1371/journal.ppat.1009134.g003
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The Ae. aegypti SUMOylation pathway has broad antiviral activity against
arbovirus infection
We next assessed the biological significance of the Ae. aegypti SUMOylation pathway during
arbovirus infection. AF5 cells were treated with gene-specific (AaSUMO, AaUbc9, AaPIAS) or
negative control (lacZ) dsRNA to transiently deplete SUMOylation effector proteins. As a posi-
tive control, AF5 cells were treated with a dsRNA targeting an effector of the exo-RNA inter-
ference (RNAi) pathway (ago2), which has known antiviral activity against SFV [35,36],
BUNV [37], but not ZIKV [36,38,39]. Transfected cells were infected (MOI 0.05 PFU/cell)
with luciferase reporter viruses from three independent arboviral families: BUNV (Orthobu-
nyavirus, Bunyaviridae); SFV (Alphavirus, Togaviridae); or ZIKV (Flavivirus, Flaviviridae).
These reporter viruses have been previously used to analyse the antiviral action of Ago2 and
Fig 4. AaSUMO is differentially expressed in Ae. aegypti tissues. (A) RNA was extracted from perfused haemocytes, dissected salivary glands,
digestive tracts, ovaries, and carcasses (pools of 25 digestive tracts, ovaries or carcasses, 60 salivary glands, or pooled perfused haemocytes from 70
females per replicate experiment, N = 3 independent experiments). cDNA was synthesised and RT-qPCR was conducted to examine mRNA
expression of SUMO. Data were analyzed as described by Taylor et al. (78). SUMO expression values were normalized to ribosomal S7 as a
reference transcript, with a RQ geometric mean (geomean) of 1 for carcass. SD shown. Log2-normalized expression values were used for
statistical analyses; one-way ANOVA (F4,10 = 17.99, p = 0.0001) followed by a Dunnett multiple comparison test relative to carcass (p values
shown). (B to L) Representative confocal microscopy images showing the expression and sub-cellular localization of SUMO (red) in Ae. aegypti
cells and tissues as detected by immunofluorescence assay. (B,C) AF5 cells; (D) perfused prohaemocytes; (E) perfused granulocytes; (F,G) salivary
glands and surrounding fat body; (H) midgut; (I) oviduct; (J) ovarioles surrounded by the ovarian sheath; and (K,L) primary previtellogenic
follicle and germarium inside ovarioles. Nuclei are stained by DAPI (blue) and F-actin is stained by Phalloidin 488 (green). Bar = 20 μm. Arrows
indicate SUMO accumulation around the nucleus of the future oocyte (white) and at the perinuclear region of the nurse cells (yellow).
https://doi.org/10.1371/journal.ppat.1009134.g004
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shown to be as genetically stable as their respective wild-type viruses (SFV [36,40–42]; BUNV
[37]; ZIKV [43]). Transcript levels of SUMO, Ubc9, PIAS, and ago2 were decreased from 50 to
80% relative to dsLacZ-treated control cells (Fig 5A, 5D and 5G), validating the efficiency of
dsRNA depletion. As expected, depletion of Ago2 led to a significant increase in BUNV and
SFV, but not ZIKV, replication relative to infected dsLacZ control cells (Fig 5B, 5E and 5H,
respectively). Importantly, depletion of AaSUMOylation pathway effectors (AaSUMO,
AaUbc9, and AaPIAS) led to significantly higher levels of BUNV, SFV, and ZIKV replication
Fig 5. AaSUMOylation effector proteins suppress arbovirus replication in Ae. aegypti cells. AF5 cells were treated with dsRNA targeting SUMO, Ubc9, PIAS,
LacZ (non-target negative control), or ago2 (positive control) for 72 hours prior to infection (MOI 0.05 PFU/cell) with BUNV, SFV, or ZIKV luciferase reporter
viruses. Cells were harvested at 48 hours post-infection for luciferase and RT-qPCR analysis. (A,D,G) RT-qPCR analysis of mRNA levels of ago2, SUMO, Ubc9, or
PIAS within infected AF5 cells. N = 5 independent biological replicates; values normalized to ribosomal S7 and expressed relative to dsLacZ-treated control
samples; RQ mean and SD plotted. (B, E, H) Luciferase readings from BUNV, SFV, or ZIKV infected samples. N = 15 independent biological replicates per
condition; values expressed relative to dsLacZ-treated control samples (set to 1, dotted line); mean and SD plotted. (C, F, I) Viral RNA (vRNA) levels from BUNV,
SFV, or ZIKV infected samples. N = 5 independent biological replicates; values expressed relative to dsLacZ-treated control samples (set to 1, dotted line); RQ
mean and SD plotted. Statistical analysis, one sample (two-tailed) t test to a hypothetical mean of 1 (dsLacZ control), significant probability (P) values (� 0.05)
shown; ns = not significant.
https://doi.org/10.1371/journal.ppat.1009134.g005
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independently of the effector protein targeted for depletion (Fig 5B, 5E and 5H, respectively).
These data indicate that multiple component proteins of the AaSUMOylation pathway con-
tribute to the suppression of arbovirus replication; with BUNV and SFV being the most sus-
ceptible to AaSUMOylation-mediated restriction. Significant increases in BUNV, SFV, and
ZIKV intracellular RNA levels could also be observed in cells depleted for AaSUMOylation
proteins (Fig 5C, 5F and 5I, respectively); with SFV demonstrating the greatest increase in
viral RNA (vRNA) levels (up to 10-fold relative to dsLacZ-treated control cells). It remains to
be determined why depletion of AaUbc9 or AaPIAS had no significant effect on the intracellu-
lar levels of BUNV RNA. However, this may reflect the relative level of effector protein deple-
tion between replicate experiments (Fig 5A; Ubc9). In the majority of cases, disruption of the
AaSUMOylation pathway led to increases in both arbovirus replication (Fig 5B, 5E and 5H)
and intracellular vRNA levels (Fig 5C, 5F and 5I). Collectively, these data indicate that the
AaSUMOylation pathway has a broad antiviral action against arboviruses from multiple fami-
lies in Ae. aegypti cells.
Discussion
The antiviral defences of mosquitoes are key determinants of vector competence, i.e. the ability
of mosquitoes to get infected by an arbovirus following an infectious blood meal and subse-
quently transmit it to a new vertebrate host [44]. In mosquitoes, several pathways have been
reported to play a role in the control of arbovirus infection. These include the RNAi and evolu-
tionarily conserved innate immune pathways, such as the NF-κB signalling pathways (Toll and
Imd) and the Janus kinase-signal transduction and activators of transcription (JAK/STAT)
pathway [45,46]. Here, for the first time, we identify the Ae. aegypti SUMOylation pathway as
being another evolutionarily conserved pathway that supresses arbovirus replication in mos-
quito cells.
To date, the majority of SUMO studies in arthropods has been conducted in D. melanoga-
ster, which is known to possess a single SUMO gene (smt3; [47]). In contrast, two homologous
SUMO genes have been previously identified in the Ae. aegypti genome [24,25]. Our analysis
using the most recent annotated sequence [27] could only identify one SUMO gene
(AAEL015064), a finding supported by our mass spectrometry analysis which identified
unique peptides to all core effector proteins of the Ae. aegypti SUMOylation pathway
(AaSUMO, AaSAE1/2, AaUbc9, and AaPIAS). We demonstrate that AaSUMO is highly
related to HsSUMO3, but lacks an N-terminal SCM restricting its ability to support poly-
SUMO chain formation. Our analysis supports previous studies, which have suggested this
motif to be lost in insects, but to be present in vertebrates and ticks [24,25]. Addition of
AaPIAS stimulated the accumulation of HMW AaSUMO conjugates in an SP-RING depen-
dent manner, demonstrating AaPIAS to be a functionally conserved SUMO E3 ligase in mos-
quito cells. Notably, AaPIAS promoted AaSUMO conjugation onto multiple solvent exposed
Lys residues, indicating that AaPIAS may stimulate the formation of multiple or branched
poly-SUMO chain types. This contrasts with poly-SUMO2/3 chain formation in vertebrate
cells, which can occur independently of SUMO E3 ligase activity in a SCM K11-dependent
manner [14]. This highlights an additional level of regulation required for the formation of
poly-SUMO chains in Ae. aegypti, which are known to play many important biological roles in
mammalian cells [16]. It remains to be determined if AaPIAS, or other functionally conserved
SUMO ligases, significantly contribute to poly-AaSUMO chain formation in vivo. Our mass
spectrometry and western blot analysis revealed that AaSAE2 is SUMO modified in vitro, the
levels of which are significantly enhanced in the presence of AaPIAS in a SP-RING dependent
manner. In H. sapiens, SUMO modification of SAE2 leads to altered protein sub-cellular
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localisation and reduced affinity for Ubc9 [32,33]. Thus, SAE2 auto-SUMOylation is likely to
be a functionally conserved property of the SAE1/2 heterodimeric complex, although further
studies are required to confirm the biological importance of this phenotype in Ae. aegypti cells.
The analysis of SUMO expression in NBF female Ae. aegypti reveals that SUMO is
expressed in haemocytes (mosquito immune cells) and in various tissues, including the diges-
tive tract, the ovaries, and the fat body. Our analysis demonstrated SUMO transcript to be
ubiquitously expressed throughout Ae. aegypti, with the highest levels of expression in the ova-
ries and haemocytes. Of note, previous microarrays and RNA-seq studies have shown that
SUMO expression levels in whole females do not change upon blood feeding and ZIKV infec-
tion [48,49]. Similar ubiquitous tissue expression of SUMO (smt3) in D. melanogaster has been
found by RNA-seq, with an enrichment in ovaries (http://flyatlas.gla.ac.uk/FlyAtlas2/index.
html). Although the expression of SUMO has yet to be reported in the haemocytes of adult
flies, Ubc9 (lesswright, Lwr) is specifically required in larval haemocytes for haematopoiesis
[50], suggesting that SUMO is expressed in Drosophila haemocytes. SUMO and Ubc9 are also
ubiquitously expressed in the shrimp species Fenneropenaeus chinensis [51], with high levels of
expression in haemocytes and ovaries. Thus, the tissue expression profile of SUMO in arthro-
pods seems to be conserved across evolution. Indeed, Ubc9 is highly expressed in the repro-
ductive organs and the blood cells in the fish Cynoglossus semilaevis [52] and in immune cells,
endocrine tissues, reproductive tissues, and adipose tissues in H. sapiens (Human Protein
Atlas, https://www.proteinatlas.org/) [53,54].
In many of the Ae. aegypti tissues and cells studied here, SUMO is predominantly expressed
in punctate structures in the nuclei. This pattern of expression in mammalian cells is due to
the extensive SUMO modification of Promyelocytic leukaemia nuclear bodies (PML-NBs), a
process required for PML-NB formation and associated protein-protein interactions [55].
PML-NBs are involved in many cellular processes, including the cell cycle, genome stability,
and antiviral defence, through the SUMO-dependent sequestration, modification, and degra-
dation of associated host factors [56]. The PML gene is not evolutionarily conserved among
eukaryotes, being absent in lower eukaryotes such as insects [57]. However, as many other
RING containing proteins (including other TRIM family members like PML; TRIM19) can
form nuclear structures, including in insects [58], it is possible that SUMO modification of
other RING proteins is involved in the formation of nuclear complexes in mosquito cells with
similar regulatory functions.
SUMO modification is known to regulate the biological function of hundreds of cellular
proteins [11]. Previous studies have clearly established a role of SUMOylation, both positive
and negative, in the replication of DNA and RNA viruses in mammalian cells [17–19]. The
SUMOylation pathway is also known to influence arbovirus replication in H. sapiens cells,
although its pro- or antiviral action is still a matter of debate and warrants additional study
[20–23]. We have now shown that the SUMOylation pathway influences replication of a range
of arboviruses in Ae. aegypti cells. Indeed, depletion of components of the SUMOylation path-
way led to a consistent increase in viral replication and intracellular RNA levels of BUNV,
SFV, and ZIKV; albeit to varying extents. Such differences may reflect virus-specific interfaces
with the AaSUMOylation pathway that requires further study. Importantly, depletion of
SUMO effector proteins led to an increase in viral replication of BUNV and SFV equivalent to
that of Ago2 depletion, a key mediator of the Ae. aegypti antiviral RNAi pathway [46]. Thus,
we identify the AaSUMOylation pathway to contribute to the antiviral immune response to
arbovirus infection in mosquito cells. However, we cannot discount a positive (pro-viral) role
for AaSUMOylation, as there may well be virus-specific requirements for host SUMOylation
in certain mosquito cell types or tissues. Notably, AaPIAS depletion had an overall weaker
effect on SFV replication in mosquito cells relative to that of Ubc9 depletion. Such differences
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may be linked to virus-specific requirements for component proteins of the AaSUMOylation
pathway to restrict arbovirus replication. Previous studies suggest that members of the H. sapi-
ens PIAS family of E3 ligases, which are primarily known for their role as negative regulators
of innate immunity, also possess intrinsic immune functions to suppress viral replication in
mammalian cells [59–61]. In Ae. aegypti, transient depletion of AaPIAS decreased DENV and
ZIKV infection intensity in the midgut [62,63], consistent with PIAS proteins being negative
regulators of the JAK/STAT pathway. By way of contrast, activation of the JAK/STAT pathway
in the mosquito fat body decreased DENV infection while it had no effect on ZIKV and
CHIKV [64]. These data suggest virus- or tissue-specific roles for the JAK/STAT pathway in
the immune regulation of arbovirus infection in mosquito cells, which may account for why
we did not observe an overall net decrease in arbovirus replication following AaPIAS depletion
in our study.
Collectively, our results demonstrate that the sequence, function, and tissue distribution of
the Ae. aegypti SUMOylation pathway effector proteins are highly conserved. We have shown
the SUMO pathway to suppress arbovirus replication from three independent viral families.
Thus, we identify SUMOylation as an additional conserved pathway involved in antiviral
defences in cells derived from Ae. aegypti. Our data helps to fill many long-standing gaps in
the literature about the conservation and biochemical properties of the SUMOylation pathway
in this transmitting vector species, and the overall net functional effect of Ae. aegypti SUMO
modification during arbovirus replication. Areas for future research include determining in
which tissues and cell types, where arboviruses can replicate (e.g. gut, salivary glands, and hae-
mocytes; [65–67]), and how, mosquito SUMOylation controls arbovirus replication. Further
analyses using tissue-specific genetic tools and vector-specific antibodies will be required to
assess the precise location and mechanisms of restriction in Ae. aegypti.
SUMOylation can influence the function of a wide variety of proteins and cellular pro-
cesses. Nevertheless, some hypotheses explaining the antiviral action of SUMOylation in mos-
quito cells can be proposed. In D. melanogaster, SUMOylation occurs on diverse immune
proteins that can modulate innate immune function, including JAK/STAT and Imd patways
[26,68,69]. In arbovirus (BUNV, SFV, and ZIKV) infected mosquito cells silenced for Ubc9,
we failed to observe a significant decrease of vir-1 (JAK-STAT effector, [70]) or cecropin D
(Imd effector, [71] expression (S6 Fig), which suggests that AaSUMOylation does not directly
influence the transcription of these effector proteins. However, we cannot exclude that AaSU-
MOylation could enhance the expression, stability, or function of other innate immune regula-
tors to mediate an antiviral effect in mosquito cells. Alternatively, arboviral proteins may be
targeted directly for SUMOylation to modulate their function or stability, as observed for the
DENV NS5 protein in mammalian cells [23]. Further studies are warranted to determine the
precise mechanism(s) associated with the antiviral role(s) of host SUMOylation in Ae. aegypti
cells that suppress arbovirus replication.
Materials and methods
Cell culture
Ae. aegypti cell lines A20 and AF5 [40,72,73] were maintained in Thermo Fisher Scientific
Nunclon Delta surface (25 cm2) tissue culture flasks with Leibovitz’s L-15 media (Gibco) sup-
plemented with 10% (w/v) Tryptose phosphate broth (TPB; Gibco) and 10% (w/v) Foetal
Bovine Serum (FBS; Gibco). BHK-21 cells (obtained from Roger D. Everett [MRC-UoG
CVR]) were cultured in GMEM (Gibco), supplemented with 10% TPB and 10% FBS, Vero-E6
cells (obtained from Claire Donald [MRC-UoG CVR]) were cultured in DMEM (Gibco) sup-
plemented with 10% FBS. A549-Npro cells (obtained from Claire Donald [MRC-UoG CVR])
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were also cultured in DMEM (Gibco), supplemented with 10% FBS and 0.5 μg/ml puromycin.
A549-Npro, BHK-21 and Vero-E6 cells were grown at 37˚C with 5% CO2, A20 and AF5 cells
were cultured at 28˚C.
Virus stocks
Semliki Forest virus (SFV) with a firefly luciferase reporter (SFV4-FFluc described in [74]) was
a kind gift from Dr. Esther Schnettler (MRC-UoG CVR) and grown and titrated in BHK-21
cells as previously described [42]. Stocks of BUNV encoding a NanoLuciferase reporter protein
(BUNV-NLuc described in [37]) was a kind gift from Dr. Xiaohong Shi (MRC-UoG CVR) and
grown and titrated in BHK-21 cells as previously described [75]. ZIKV encoding a NanoLuci-
ferase protein (ZIKV-NLuc described in [43]) was produced and kindly gifted by Jamie Royle
(MRC-UoG CVR) grown and titrated in Vero-E6 and A549-Npro cells, respectively as previ-
ously described [43,76].
Plasmids
AaSAE1/2 were amplified from A20 cDNA using gene-specific primers (S1 Table). CDS were
cloned into a pACYCDuet-1 dual expression vector (Sigma-Aldrich; Merck KGaA) using
EcoRI/NotI (SAE2) and NdeI/XhoI (SAE1) unique sites. A Strep.II tag (5’-TGGAGC-
CACCCGCAGTTCGAAAAG-3’) was synthesised (Dundee Cell Products) and inserted to
replace 6xHis tag sequences between NcoI-EcoRI in frame with AaSAE2. WT SUMO chi-
maera (amino acids 1–14 of HsSUMO3 and 14–91 of AaSUMO) and mutant SUMO chimaera
(K11R) CDS were synthesised (GENEWIZ), amplified with the primers ‘pET28-AaSUMO R’
and ‘pET28-SUMO chimaera F’ (S1 Table), and inserted into pET28a (Novagen) using NdeI/
XhoI restriction sites. A CDS for AaSUMO (cloned from A20 cells; a kind gift from Dr. Sue
Jacobs, Pirbright Institute) was cloned into pET28a using primers ‘pET28-AaSUMO F’ and
‘pET28-AaSUMO R’ (S1 Table) using NdeI/XhoI restriction sites. WT and mutant (C371A)
AaPIAS CDS were synthesised (GENEWIZ), amplified by PCR with the primers ‘AaPIAS F’
and ‘AaPIAS R’ (S1 Table), and cloned into a pET45b (Sigma-Aldrich; Merck KGaA) using
AgeI/NotI restriction sites. AaUbc9 was cloned from A20 cDNA using primers ‘pET45-
AaUbc9 F’ and ‘pET45-AaUbc9 R’ (S1 Table) and cloned into pET45b using AgeI/XhoI
restriction sites. Bacterial expression vectors for HsSAE1/2, HsSUMO1, HsSUMO2,
HsSUMO3, and HsUbc9 are described in [14]. All restriction enzymes were purchased from
New England Biolabs. All final constructs were confirmed by Sanger sequencing (Source
Bioscience).
Protein expression and purification
BL21 (DE3) cells were transformed with a bacterial expression plasmid containing the CDS of
interest under the appropriate antibiotic selection. Single colonies were grown in 10 ml of
Luria Bertani Broth (LB) O/N at 37˚C in an orbital shaker (200 RPM). 5 ml was added to 200
ml of LB and allowed to grow for a further 2 hours at 37˚C, 200 RPM. Protein expression was
induced with 0.1 mM isopropyl-thio-β-D-galactoside. Induction occurred in an orbital shaker
at 30˚C, 200 RPM for 4–5 hours. Bacteria were pelleted by centrifugation at 3500 x g for 10
min at 4˚C. Unless otherwise stated, the bacterial pellets were resuspended in 25 ml 6xHis
Purification Buffer (50 mM Tris (pH7.5), 250 mM NaCl, 10 mM β-mercaptoethanol, 5% glyc-
erol, 0.1% Triton-X-100, 2.5 mM MgCl2, 30 mM imidazole and a protease inhibitor cocktail
(Roche, pH 7.5). Bacteria were lysed by probe-sonication (45 pulses, 30 Amps) and centrifuged
(13,000 x g for 10 min). Bacteria containing pACYC-Strep.II-AaSAE2/1 were resuspended in 2
ml Strep Purification Buffer (50 mM Tris pH 7.0, 50 mM NaCl, 1 mM MgCl2, and a protease
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inhibitor cocktail (Roche, pH 7.5). Samples were then lysed by digital sonicator (7 repeats at
50% intensity for 30 sec, at 4˚C) and centrifuged (14,000 x g for 10 min). Supernatants con-
taining recombinant proteins were filtered through a 0.45 μm filter, bound to 250 μl (w/v) of
equilibrated Ni-NTA (Qiagen) or Strep-tactin Superflow agarose beads (Novagen) in the cor-
responding purification buffers. Samples were tumbled end-over-end for 90 min at room tem-
perature (RT), beads sedimented centrifugation (1500 x g for 5 min), washed twice in 10 ml of
purification buffer and three times in 1 ml of purification buffer. 6xHis tag proteins were
eluted in 750 μl of 6xHis Purification Buffer containing 350 mM (final concentration) imidaz-
ole at pH 7.5 prior to dialysis in Dialysis Buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 5% glyc-
erol, 2 mM MgCl2 and 5 mM β-mercaptoethanol, 0.1% Triton-X-100) for 4 hours. Strep.II-
AaSAE2/1 was eluted in 600 μl Strep Purification Buffer with 2.5 mM D-desthiobiotin (pH
8.5) prior to dialysis in Dialysis Buffer for 4 hours. Proteins were visualized by SDS-PAGE (4–
12% gradient PAGE; Invitrogen) alongside purified commercial BSA standards (BioRad) by
Coomassie brilliant blue staining. Protein concentration was determined on the Li-Cor Odys-
sey Imaging System.
Biochemical assays
Master mixes of Ae. aegypti or H. Sapiens recombinant SUMO pathway component proteins
were aliquoted into individual tubes containing SUMO, Ubc9, and SAE1/2 (50 ng each/reac-
tion), and if required, WT or mutant (C371A) PIAS (10 ng/reaction). The reaction was initi-
ated by addition of SAE1/2 and incubated at 37 or 28˚C for the desired length of time. The
reaction was terminated by the addition of 1.5xBM (Laemmli buffer supplemented with 2.6 M
Urea and 50 mM Dithiothretol). This sample mixture was boiled at 95˚C for 10 min prior to
SDS-PAGE and western blotting. Biochemical assays for Mass spectrometry analysis were per-
formed with 5 μg SUMO, 500 ng Ubc9, 500 ng SAE1/2, and 50 ng WT or C371A PIAS, and
incubated at 28˚C for 1 hour. Reactions were terminated by the addition of NuPAGE Sample
Reducing Agent (Invitrogen).
Western blots
Samples were resolved on a NuPAGE-Novex 4–12% Bis-Tris Gradient gel (Invitrogen) with
1X NuPage MES SDS running buffer (Invitrogen). PAGE gels were transferred onto an Amer-
sham protran 0.2 μm nitrocellulose blotting membrane (GE Healthcare) in transfer buffer (1x
NuPage transfer buffer and 10% Methanol) at 30 V for 60 min. The membranes were blocked
in blocking buffer (5% FBS in PBS) for 1 hour. The mouse anti-SUMO2/3 primary antibody
(Cat. No. Ab81371; Abcam) diluted 1:1,000 in blocking buffer was incubated on the blotting
membrane for 1 hour or O/N at 4˚C. The membrane was washed 3 times for 5 min in PBST
(0.1% Tween-20). A DyLight800 fluorescent goat anti-mouse secondary antibody (SA535521;
Thermo Fisher Scientific) diluted 1:10,000 was incubated with the membrane for 1 hour. All
steps were conducted at room temperature unless stated otherwise. Membranes were imaged
and quantified using a LiCor Odyssey Imaging System.
dsRNA production
Total RNA was extracted from Ae.aegypti-derived A20 cells using an RNAeasy Plus Kit (Qia-
gen), following manufacturer’s instructions. cDNA was synthesised with TaqMan Reverse
Transcription Reagents kit (Life Technologies) with Random Hexamer primers according to
the manufacturer’s instructions. To synthesise dsRNA, cDNA was amplified with gene-specific
primers (S1 Table) incorporating the T7 RNA polymerase promoter sequence at the 5’ end.
PCR was conducted using Phusion polymerase (New England Biolabs), PCR products were
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excised from the gel using QIAquick Gel Extraction Kit (Qiagen), and sequenced to confirm
identity by Sanger sequencing (Source Bioscience). dsRNA were produced using the MEGA-
script RNAi kit (Ambion) according to the manufacturer’s instructions. The dsRNA were
quantified using a Nanodrop spectrophotometer.
dsRNA transfection and infection
AF5 cells (2.5x105 / well) were seeded in 24-well plates and left in the incubator overnight (O/
N) at 28˚C prior to the transfection of 300 ng dsRNA with 2 μl DharmaFECT2 (Dharmacon)
per well, following manufacturer’s instructions. Cells were incubated for 72 hours prior to
infection (MOI of 0.05 PFU per cell). After 48 hours, cells were harvested for RT-qPCR (viral
load and depletion efficiency) or luciferase analysis.
Luciferase assay
Luciferase expression was determined using the Luciferase Assay System Kit (Promega) for
SFV-Ffluc and the Nano-Glo Luciferase Assay System Kit (Promega) for BUNV-NLuc and
ZIKV-NLuc. Luciferase activities were determined on a GloMax 20/20 Luminometer following
the manufacturer’s instructions. A minimum of 5 independent biological repeats were con-
ducted in triplicate for each experimental condition.
Mosquito rearing
Ae. aegypti mosquitoes (Liverpool strain, gift from Pr. Eileen Devaney, University of Glasgow)
were reared at 28˚C and 80% humidity with a 12:12 light photoperiod. Larvae were reared in
water with some dry pieces of cat food pieces from larvae hatching to pupal stage. Emerging
adult mosquitoes were transferred in cages with unlimited access to 10% w/v sucrose solution.
For rearing, female mosquitoes were fed on rabbit blood supplemented with heparin (Orygen
Antibodies Ltd) using a Hemotek (Hemotek Ltd., UK) at 37˚C.
Dissection of mosquito tissues and perfusion of haemocytes
Tissues were dissected from 5 day-old females in RNase free 0.05% PBS-Tween 20 (PBST) (v/
v). For RNA extraction, tissues were stored at -80˚C. For immunostainings, tissues were stored
in PBS-T 0.05% on ice before fixation. Haemocytes were collected by perfusion. The last seg-
ment of the abdomen was cut and mosquitoes were then injected in the thorax with 0.01%
PBS-T. For RT-qPCR experiments, PBS-T diluted haemocytes were collected in tubes on ice,
further centrifuge at 2,000 RPM for 15 min at 4˚C. The supernatant was removed before the
addition of TRIzol reagent (Thermo Fisher Scientific). For immunostainings, haemocytes
were perfused on slides (ibidi) which were incubated for 30 min at 28˚C before removal of
PBS-T for fixation and staining.
RNA extraction and reverse transcription (RT)-quantitative PCR
Total RNA was isolated from cells using the RNAeasy Plus Kit (Qiagen), following manufac-
turer’s instructions. cDNA was synthesised with TaqMan Reverse Transcription Reagents kit
(Life Technologies) with Random Hexamer primers, as per manufacturer’s instructions. Sam-
ples were analysed in triplicate using SYBR Green Master mix (Applied Biosystems) with
gene-specific primers (S1 Table). Quantitative PCR (qPCR) was conducted on an Applied Bio-
systems 7500 Fast-Real-Time PCR system using MicroAmp plates and Optical Adhesive cov-
ers (Applied Biosystems). Relative mRNA expression levels were determined using the 2−ΔΔCt
(cycle threshold) method [77], normalised to the S7 ribosomal gene and presented as relative
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values to that of the dsLacZ control. Data presented for the knockdown efficiency and the viral
loads is the mean of 5 independent biological repeats. RQ means and standard deviations are
presented.
Dissected mosquito tissues (pools of 25 digestive tracts, ovaries or carcasses, pools of 60 sali-
vary glands, and pools of perfused haemocytes from 70 females per independent replicate)
were homogenised in TRIzol (Thermo Fisher Scientific) with glass beads using the Precellys 24
homogeniser (Bertin Instruments). RNA from tissues and haemocytes were further extracted
using the Trizol method according to the manufacturer’s instructions except that 1-Bromo-
3-chloropropane (Sigma) was used instead of chloroform and DNase (TURBO DNase,
Ambion) treatment was performed. Reverse-transcriptions (RT) and RT negative controls
were performed using the MMLV retro-transcriptase (Promega) from 25 ng/μl of RNA
according to the manufacturer’s instructions. cDNAs were aliquoted and stored at -20˚C until
qPCR. qPCR was performed using Fast SYBR Green master mix (Applied Biosystems) follow-
ing the manufacturer’s instructions using the 7500 Fast machine (Applied Biosystems). Prim-
ers used are listed in S1 Table. Results were analysed with the 7500 Software v2.0.6. Data were
analyzed as described by Taylor et al. [78] to obtain normalized expression values, relative to
ribosomal S7 transcript expression, with a geometric mean (geomean) of 1 for the carcass con-
dition. Log2-normalized expression values were used for statistical analyses.
Immunofluorescence assays
Salivary glands and ovaries (n�10 of each per replicate) were fixed at room temperature for 20
min in 4% (w/v) paraformaldehyde (PFA) diluted in PBS-T 0.05%. AF5 cells (3x104 cells/well,
incubated O/N at 28˚C on ibidi slides), perfused haemocytes (from a pool of 5 females per rep-
licate) and guts (n�10 per replicate) were fixed the same way with the exception that the PFA
was diluted using PBS. Fixed haemocytes/tissues (except ovaries) were washed (three times, 15
min each at 4˚C) in PBS-T 0.05%, before being blocked for a minimum of 30 min in blocking
solution (0.25% PBS-T 5% FBS (v/v), 5% BSA (w/v), 0.25% Triton X-100 (v/v) at 4˚C. Unlike
other tissues, ovaries were dilacerated and washed in 1% PBS-T before being blocked in block-
ing solution containing 0.5% Tween and 0.5% Triton. AF5 cells, haemocytes, and tissues were
incubated at 4˚C overnight with a mouse anti-SUMO2/3 antibody (Cat. No. Ab81371; Abcam)
diluted 1:1000 in blocking solution. For each experiment, a negative control without primary
antibody was performed. Samples were washed (five times, 15 min each at 4˚C) in 0.05%
PBS-T (0.5% PBS-T for ovaries) and incubated with an Alexa Fluor 568 goat anti-mouse IgG
(H+L) diluted 1:1,000, DAPI 1X (405 nm) and Phalloidin 1X (488 nm) in blocking solution
for 2 hours at RT. Four washes in 0.05% PBS-T (0.5% PBS-T for ovaries) were done and tissues
were mounted between a slide and coverslip (24 mm x 24 mm) with an imaging spacer (1 well,
diam. x thickness 13 mm x 0.12 mm Grace Bio-Labs SecureSeal imaging spacer, Sigma-
Aldrich) using ibidi Mounting Medium (ibidi). Mounting media was used to replace the
PBS-T in haemocytes. Images were acquired on a Zeiss LSM 710 inverted confocal micro-
scope, equipped with a 40X or 63X oil-immersion objective and processed with Fiji/ImageJ
and Adobe Photoshop. Two independent replicates were performed.
Shotgun proteomic analysis to identify expressed SUMO pathway proteins
AF5 cell extracts were harvested in 1.5XBM and proteins fractionated by 4–12% Bis-tris
SDS-PAGE gel running in MES buffer. Each lane was excised into 12 slices and tryptic pep-
tides extracted as described previously [79]. All 132 peptide samples were analyzed by LC-MS/
MS on a Q Exactive mass spectrometer (Thermo Scientific) coupled to an EASY-nLC 1000 liq-
uid chromatography system via an EASY-Spray ion source (Thermo Scientific) running a
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75 μm x 500 mm EASY-Spray column at 45˚C. Peptides were fractionated over a 90 minute
gradient and data were acquired in the data-dependent mode. Full scan spectra (m/z 300–
1800) were acquired with resolution R = 70,000 at m/z 200 (after accumulation to a target
value of 1,000,000 with maximum injection time of 20 ms). The 10 most intense ions were
fragmented by HCD and measured with a resolution of R = 17,500 at m/z 200 (target value of
500,000, maximum injection time of 60 ms) and intensity threshold of 2.1x104. Peptide match
was set to ‘preferred’ and a 40 second dynamic exclusion list was applied. The resultant 132
raw MS data files were processed using MaxQuant (v 1.6.1.0) with the built-in Andromeda
peptide search engine [80]. The Ae. aegypti uniprot protome (downloaded August 2017) was
searched. Enzyme specificity was set to trypsin-P. Cysteine carbamidomethylation was selected
as a fixed modification with methionine oxidation and protein N-terminal acetylation as vari-
able modifications. Initial maximum allowed mass deviation was set to 20 parts per million
(ppm) for peptide masses and 0.5 Da for MS/MS peaks. The minimum peptide length was set
to 7 amino acids and maximum size 4600 Da. A maximum of two missed cleavages were con-
sidered. A false discovery rate (FDR) of 1% was required at both the protein and peptide levels.
The ‘match between runs’ option was applied with a time window of two minutes matching
between samples from the same gel slice position across different lanes, or a slice above or
below. 5462 protein groups were identified after removal of decoy proteins, putative contami-
nants and those only identified by modified peptide. Peptide level data for SUMO, Ubc9,
SAE1, SAE2 and PIAS proteins are shown in S1 File.
Shotgun proteomic analysis of in vitro SUMO conjugation reactions to
identify sites of polymerisation
Three in vitro SUMO conjugation reactions were prepared in triplicate: without any E3, with
WT PIAS, or with C371A mutant PIAS (see above). Proteins were fractionated by 10% Bis-tris
SDS-PAGE gel running in MOPS buffer. Each lane was excised into upper and lower slices to
gain information on SUMO-SUMO dimers, and high molecular weight polymers. Tryptic
peptides were extracted as described above. Half of each tryptic peptide sample was further
subjected to in solution digestion with GluC to shorten the C-terminal SUMO adduct attached
to substrate peptides, hence increasing likelihood of detection of as many SUMO conjugation
sites as possible. Two mass spectrometry runs were performed for tryptic peptides and one for
the doubly digested Trypsin-GluC peptides. Instrument setting were essentially as described
above except for the second trypic peptide run and the only Try-GluC run for which a top1
method was applied with a 1000ms fill time. These settings improve MS/MS spectra for large
low abundance peptides. To automatically detect branched peptides a concatenated database
approach was taken, similar to previously described [81]. Briefly, a sequence file in fasta format
was generated whereby the C-terminus of SUMO was concatenated to all conceivable peptides
yielded by protease digestion of SUMO, Ubc9, SAE1 and SAE2. This concatenated sequence
database contains individual ‘proteins’ that mimic the SUMO-substrate branched peptides
allowing MaxQuant to automatically search for them in the MS data. MaxQuant was set up as
described above except the concatenated peptide fasta file was used along with a file containing
all proteins present in the in vitro reactions, GluC and Try/P (6 missed cleavages) or just Try/P
alone (4 missed cleavages) were defined as proteases, and max peptide mass was set to 10000.
Representative spectra can be found in S7–S14 Figs and data summary can be found in S2 File.
Bioinformatics and statistical analysis
Amino acid alignment was conducted using the online software T-COFFEE (http://tcoffee.crg.
cat/) [82]. These results were then plotted and exported with BOXSHADE (https://embnet.
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vital-it.ch/software/BOX_form.html). Models of AaSUMO were conducted by obtaining the
annotated amino acid sequence from UniProt, and predicting the tertiary structure with
Phyre2 and plotting the structure in Chimera 1.10.1 [83,84]. Statistical analysis and graphs
were produced using GraphPad Prism 7.02. Statistical tests are indicated in figure legends.
Supporting information
S1 Fig. Recombinant SUMOylation pathway proteins. 6xHis- or Strep.II-tagged proteins of
the (A) H. sapiens and (B) Ae. aegypti SUMOylation pathways were expressed in bacteria and
purified through Nickle- or Biotin-affinity chromatography. Samples were resolved by
SDS-PAGE and Coomassie stained. A BSA gradient is included to assess concentration.
Molecular weights indicated.
(JPG)
S2 Fig. Schematic of the mass spectrometry protocol. Coomassie gel showing in vitro conju-
gation assay products from reactions either lacking AaPIAS (-), or including wild-type (WT)
or inactive C371A mutant variants (CA). Schematic explaining sample processing and mass
spectrometry analysis using a branched peptide database is shown.
(JPG)
S3 Fig. Predicted location of acceptor lysine residues with AaSUMO. SUMO internal lysine
residues identified as being prominent acceptors of SUMO modification in Fig 3 were plotted
on the predicted structure of AaSUMO (blue). Green indicates poor acceptors of SUMO mod-
ification (total branched peptide intensity <3x109), while magenta indicates the lysine residues
which are predominantly modified (total branched peptide intensity >3x109). K19, K31, and
K34 are shown in green, while K5, K6, K9, K33, and K40 are in magenta. (A) Front view. (B)
Top view. (C, D) side view rotated ± 90˚ from A.
(JPG)
S4 Fig. AaSUMO is differentially expressed in Ae. aegypti tissues. Data presented on Fig 4A
were subjected to an ANOVA test (F4,10 = 17.99, p = 0.0001) followed by a Tukey’s post hoc
multiple comparison test. Letters above bars indicate post hoc significance. Groups with the
same letter are not significantly different. Table shows p values for each group comparison.
(JPG)
S5 Fig. No primary antibody control IFA in haemocytes and tissues of females Aedes
aegypti. Immunofluorescence assay without primary antibody on perfused haemocytes (A),
salivary glands (B), midgut (C) and ovaries (D). The signal was revealed by an Alexa Fluor 568
goat anti-mouse IgG (H+L) diluted 1:1000 (red). Nuclei are stained by DAPI (blue) and F-
actin is stained by Phalloidin 488 (green). The images were acquired on a Zeiss LSM 710
inverted confocal microscope with 40X or 63X oil-immersion objective and using the same
parameters as those used for samples incubated with anti-SUMO primary antibody (Fig 5).
Scale bar is 20 μm.
(JPG)
S6 Fig. Expression of vir1 and cecropin D in Ae. aegypti infected cells depleted for Ubc9.
Expression of vir1 and cecropin D (cecD) was analysed in dsUbc9- and dsLacZ-treated cells (as
described in Fig 5) by RT-qPCR. N = 5 independent biological replicates. Values normalized
to ribosomal S7 and expressed relative to dsLacZ-treated control samples set to 1; RQ mean
and SD plotted. Statistical analysis, one sample (two-tailed) t test to a hypothetical mean of 1
(dsLacZ control), significant probability (P) values (� 0.05) shown. (A, B, C) Expression of
vir1 in BUNV-, SFV- and ZIKV-infected cells, respectively. (D, E, F) Expression of cecropin D
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in BUNV-, SFV- and ZIKV-infected cells, respectively.
(JPG)
S7 Fig. Evidence for AaSUMO polymerisation at lysine 5. (A, B) Best spectra for two differ-
ent peptides providing evidence for polymerisation of AaSUMO via lysine 5. See S2 File for
details. Note, due to the use of a concatenated database of N-terminal fusions of the SUMO C-
terminus to potential substrate peptides, many fragments are not annotated. These are mostly
b series ions from the substrate peptide up to the modified lysine.
(JPG)
S8 Fig. Evidence for AaSUMO polymerisation at lysine 6. (A, B) Best spectra for two differ-
ent peptides providing evidence for polymerisation of AaSUMO via lysine 6. See S2 File for
details. Note, due to the use of a concatenated database of N-terminal fusions of the SUMO C-
terminus to potential substrate peptides, many fragments are not annotated. These are mostly
b series ions from the substrate peptide up to the modified lysine.
(JPG)
S9 Fig. Evidence for AaSUMO polymerisation at lysine 9. (A, B) Best spectra for two differ-
ent peptides providing evidence for polymerisation of AaSUMO via lysine 9. See S2 File for
details. Note, due to the use of a concatenated database of N-terminal fusions of the SUMO C-
terminus to potential substrate peptides, many fragments are not annotated. These are mostly
b series ions from the substrate peptide up to the modified lysine.
(JPG)
S10 Fig. Evidence for AaSUMO polymerisation at lysine 19. (A, B) Best spectra for two dif-
ferent peptides providing evidence for polymerisation of AaSUMO via lysine 19. See S2 File
for details. Note, due to the use of a concatenated database of N-terminal fusions of the SUMO
C-terminus to potential substrate peptides, many fragments are not annotated. These are
mostly b series ions from the substrate peptide up to the modified lysine.
(JPG)
S11 Fig. Evidence for AaSUMO polymerisation at lysine 31. Best spectrum for the only pep-
tide providing evidence for polymerisation of AaSUMO via lysine 31. See S2 File for details.
Note, due to the use of a concatenated database of N-terminal fusions of the SUMO C-termi-
nus to potential substrate peptides, many fragments are not annotated. These are mostly b
series ions from the substrate peptide up to the modified lysine.
(JPG)
S12 Fig. Evidence for AaSUMO polymerisation at lysine 33. (A, B) Best spectra for two dif-
ferent peptides providing evidence for polymerisation of AaSUMO via lysine 33. See S2 File
for details. Note, due to the use of a concatenated database of N-terminal fusions of the SUMO
C-terminus to potential substrate peptides, many fragments are not annotated. These are
mostly b series ions from the substrate peptide up to the modified lysine.
(JPG)
S13 Fig. Evidence for AaSUMO polymerisation at lysine 34. (A, B) Best spectra for two dif-
ferent peptides providing evidence for polymerisation of AaSUMO via lysine 34. See S2 File
for details. Note, due to the use of a concatenated database of N-terminal fusions of the SUMO
C-terminus to potential substrate peptides, many fragments are not annotated. These are
mostly b series ions from the substrate peptide up to the modified lysine.
(JPG)
PLOS PATHOGENS SUMOylation pathway is antiviral against arboviruses in mosquitoes
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009134 December 22, 2020 19 / 25
S14 Fig. Evidence for AaSUMO polymerisation at lysine 40. (A, B) Best spectra for two dif-
ferent peptides providing evidence for polymerisation of AaSUMO via lysine 40. See S2 File
for details. Note, due to the use of a concatenated database of N-terminal fusions of the SUMO
C-terminus to potential substrate peptides, many fragments are not annotated. These are
mostly b series ions from the substrate peptide up to the modified lysine.
(JPG)
S1 Table. Primer sequences.
(DOCX)
S1 File. Peptide level data for SUMO, Ubc9, SAE1, SAE2 and PIAS proteins in Ae. aegypti
AF5 cells.
(XLSX)
S2 File. Data summary of shotgun proteomic analysis of in vitro SUMO conjugation reac-
tions to identify sites of polymerisation.
(XLSX)
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